Teva Pharmaceutical Industries LtdTEVA:TLV

230.00 / 1.13 %
16.63 %
Close in ILAToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of May 24 2016 15:24 BST.


On Tuesday, Teva Pharmaceutical Industries Ltd (TEVA:TLV) closed at 20,050, 5.86% above its 52-week low of 18,940, set on May 16, 2016.

52-week range
May 16 2016
Jul 27 2015
Markit short selling activity
Day high20,050
Day low19,730
Previous close20,280
Average volume590.54k
Shares outstanding1.02bn
Free float1.02bn
P/E (TTM)27.02
Market cap205.61bn ILS
Annual div (IAD)460.27 ILA
Annual div yield (IAD)2.27%
Div ex-dateMay 24 2016
Div pay-dateJun 07 2016
Data delayed at least 20 minutes, as of May 24 2016 15:24 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Teva Pharmaceutical Industries Ltd+2.56 %-6.40 %-16.49 %-16.63 %+16.98 %
TASE TA-100 IDX+2.10 %-4.43 %-7.92 %-16.57 %+9.25 %
IL/HEALTH CARE+2.49 %-7.46 %-19.47 %-19.67 %+14.71 %
IL/PHARMACEUTICALS+2.49 %-7.46 %-19.47 %-19.67 %+14.71 %
Data delayed at least 20 minutes, as of May 24 2016 15:24 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.